Somkanya Tungsanga
Overview
Explore the profile of Somkanya Tungsanga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
240
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tungsanga S, Nantanawijit R, Kiatamornrak P, Kulvichit W, Ngoensawat U, Tachaboon S, et al.
BMJ Public Health
. 2025 Feb;
3(1):e001412.
PMID: 40017920
Introduction: Chronic kidney disease (CKD) is a major public health concern, and early detection is crucial to prevent adverse outcomes. Albuminuria is an early marker and key prognostic marker in...
2.
Nkunu V, Tungsanga S, Diongole H, Sarki A, Arruebo S, Caskey F, et al.
PLOS Glob Public Health
. 2024 Dec;
4(12):e0003979.
PMID: 39621612
In low- and lower-middle-income countries (LLMICs), delivering equitable kidney care presents substantial challenges, resulting in significant disparities in disease management and treatment outcomes for people with kidney failure. This comprehensive...
3.
Okpechi I, Levin A, Tungsanga S, Arruebo S, Caskey F, Chukwuonye I, et al.
BMJ
. 2024 Oct;
387:e079937.
PMID: 39401841
Objective: To assess changes in key measures of kidney care using data reported in 2019 and 2023. Design: Cross sectional survey in 148 countries. Setting: Surveys from International Society of...
4.
Okpechi I, Tummalapalli S, Chothia M, Sozio S, Tungsanga S, Caskey F, et al.
Nephrol Dial Transplant
. 2024 Sep;
39(Supplement_2):ii43-ii48.
PMID: 39235198
Background: An adequate workforce is needed to guarantee optimal kidney care. We used the International Society of Nephrology Global Kidney Health Atlas (ISN-GKHA) to provide an assessment of the global...
5.
Tungsanga S, Bello A
Drugs Aging
. 2024 Jun;
41(7):565-576.
PMID: 38926293
In an era marked by a global demographic shift towards an aging society, there is a heightened prevalence of chronic kidney disease (CKD) among older adults. The burden of CKD...
6.
Tungsanga S, Fung W, Okpechi I, Ye F, Ghimire A, Kam-Tao Li P, et al.
Am J Kidney Dis
. 2024 May;
84(4):457-468.e1.
PMID: 38788792
Rationale & Objective: Established therapeutic interventions effectively mitigate the risk and progression of chronic kidney disease (CKD). Countries and regions have a compelling need for organizational structures that enable early...
7.
Kittrakulrat J, Tiankanon K, Kerr S, Wattanatorn S, Udomkarnjananun S, Tungsanga S, et al.
Kidney Int Rep
. 2024 May;
9(4):853-862.
PMID: 38770057
Introduction: Hepatitis B virus (HBV) vaccination is crucial for seronegative patients with advanced chronic kidney disease (CKD) for protection during dialysis while preparing for transplantation. A standard regimen for HBV...
8.
Okpechi I, Luyckx V, Tungsanga S, Ghimire A, Jha V, Johnson D, et al.
Nephrol Dial Transplant
. 2024 May;
39(11):1762-1771.
PMID: 38769588
Kidney diseases have become a global epidemic with significant public health impact. Chronic kidney disease (CKD) is set to become the fifth largest cause of death by 2040, with major...
9.
Shamshad F, Tungsanga S, Senior P, Shojai S, Ghimire A, Ye F, et al.
BMJ Open
. 2024 May;
14(5):e078393.
PMID: 38760033
Introduction: Metformin is a first-line antihyperglycaemic agent for type 2 diabetes (T2DM). In addition to glycaemic control, it offers benefits related to cardiovascular health, weight neutrality and metabolic syndrome. However,...
10.
Ghimire A, Shah S, Chauhan U, Ibrahim K, Jindal K, Kazancioglu R, et al.
BMC Nephrol
. 2024 May;
25(1):159.
PMID: 38720263
Background: There is a lack of contemporary data describing global variations in vascular access for hemodialysis (HD). We used the third iteration of the International Society of Nephrology Global Kidney...